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Purpose: The goal of this study was to assess the clinicopathologic and ultrasonographic features 
of thyroid nodules with nondiagnostic results on repeat ultrasonography (US)-guided fine-
needle aspiration biopsy (FNAB) according to size and the number of suspicious findings and to 
determine the proper management of nodules with consecutive nondiagnostic results.
Methods: This retrospective study included 297 nodules with nondiagnostic results on repeat 
FNAB that were evaluated by US over the course of at least 12 months of follow-up, a follow-up 
biopsy, or an operation. We compared clinical and US variables between benign and malignant 
nodules in thyroid nodules with repeat nondiagnostic results.
Results: The comparison of benign and malignant nodules with repeat nondiagnostic 
results revealed that age, marked hypoechogenicity, irregular or microlobulated margins, 
microcalcifications, and nonparallel shape were significantly associated with malignancy. 
Multivariate logistic regression analysis in malignant nodules revealed that microcalcifications 
and irregular or microlobulated margins were independently associated with malignancy. Among 
them, only irregular or microlobulated margins were independently significant as a predictor of 
malignancy in repeatedly nondiagnostic nodules measuring >10 mm. Using receiver operating 
characteristic analysis, the best cutoff value for the “number of suspicious findings” between 
benign and malignant nodules was three in nodules of all sizes, three in nodules measuring ≤10 
mm, and two in nodules measuring >10 mm.
Conclusion: Irregular or microlobulated margins may be the most frequent US features in 
repeatedly nondiagnostic nodules >10 mm. The presence of “two or more suspicious findings” 
can be used as the cutoff for distinguishing benign and malignant nodules.
Keywords: Biopsy, fine-needle; Thyroid nodule; Ultrasonography
Received: November 28, 2015
Revised: February 29, 2016
Accepted: March 6, 2016
Correspondence to:
Eun Ju Son, MD, PhD, Department 
of Radiology, Gangnam Severance 
Hospital, Yonsei University College of 
Medicine, 211 Eonju-ro, Gangnam-gu, 
Seoul 06273, Korea
Tel. +82-2-2019-3510
Fax. +82-2-3462-5472
E-mail: EJSONRD@yuhs.ac
ORIGINAL ARTICLE
This is an Open Access article distributed under the 
terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/
licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in 
any medium, provided the original work is properly 
cited.
Copyright © 2016 Korean Society of 
Ultrasound in Medicine (KSUM)
How to cite this article: 
Eun NL, Yoo MR, Gweon HM, Park AY, Kim 
JA, Youk JH, et al. Thyroid nodules with 
nondiagnostic results on repeat fine-needle 
aspiration biopsy: which nodules should be 
considered for repeat biopsy or surgery rather 
than follow-up?. Ultrasonography. 2016 
Jul;35(3):234-243.
Thyroid nodules with repeat nondiagnostic results
e-ultrasonography.org Ultrasonography 35(3), July 2016 235
Introduction
Fine-needle aspiration biopsy (FNAB) is considered the standard first-
line method of evaluating thyroid nodules, due to its high accuracy 
and low invasiveness [1-3]. This method has significantly reduced 
the operation rate for benign nodules. Unfortunately, unsatisfactory 
or nondiagnostic results present a dilemma for clinicians and 
radiologists managing thyroid nodules, particularly nodules with 
high nondiagnostic rates in repeat biopsies or high malignancy 
rates. The Bethesda System for Reporting Thyroid Cytopathology 
[4] recommends nondiagnostic rates of ideally less than 10% of all 
FNABs; however, up to 21% of nodules have nondiagnostic results 
in initial FNAB and up to 50%-63% in repeat biopsies [5-9]. The 
recommended risk of malignancy of nondiagnostic nodules in the 
Bethesda system is 1%-4%; however, malignancy rates ranging 
from 2% to 51% have been reported [3,7,10-13].
Upon nondiagnostic initial FNAB findings, the American 
Thyroid Association (ATA), the American Association of Clinical 
Endocrinologists (AACE), the Associazione Medici Endocrinologi, 
and the European Thyroid Association [14,15] recommend repeat 
FNAB or resection for repeatedly nondiagnostic nodules. If initially 
nondiagnostic nodules still show nondiagnostic results after repeat 
FNAB, surgery is recommended for solid nodules, and surgery 
or close observation is recommended for cystic nodules [14,15]. 
However, surgery for all solid nodules is not cost-effective and 
can cause postoperative morbidity in patients. In order to avoid 
unnecessary operations, several reports have suggested that 
conservative management rather than surgery should be considered 
in low-risk groups because most repeatedly nondiagnostic nodules 
have benign outcomes [7,16]. Moon et al. [17] recommended 
surgery for nondiagnostic nodules in repeat biopsies showing 
at least one suspicious feature. However, no studies have yet 
investigated the association of “the number of suspicious findings” 
with benignity and malignancy according to size in repeatedly 
nondiagnostic nodules.  
The aim of our study was to investigate the clinicopathologic and 
ultrasonographic (US) features of thyroid nodules with repeated 
nondiagnostic results according to their size and the number of 
suspicious findings and to determine the proper management of 
nodules with consecutive nondiagnostic results. 
Materials and Methods
Study Population
This retrospective study was performed from January 2009 to 
December 2013 at a tertiary referral center. Our institutional review 
board approved the study and did not require informed consent or 
patient approval. During that period, 13,193 nodules underwent 
US-guided FNAB at our institution, of which 1,517 nodules (11.5%) 
were reported to have nondiagnostic results according to the 
Bethesda categorization. A second FNAB was performed on 772 
of these nodules, and 477 nodules (61.8%) once again showed 
nondiagnostic results. Thyroid nodules were classified as benign or 
malignant after pathological confirmation during surgery or repeat 
FNABs. Thyroid nodules that did not show significant changes or 
decreased in size over the course of at least 12 months of follow-up 
US were considered clinically benign.
Among 477 nondiagnostic nodules with repeat FNABs, 180 
Fig. 1. Study group flow chart. Flow chart shows the process through which thyroid nodules with repeat nondiagnostic results were 
included in the study. US, ultrasonography; FNAB, fine-needle aspiration biopsy.
153 Benign 74 Benign 7 Benign
19 Benign
44 Malignant
153 Nodules with benign
results on repeat FNAB
74 Nodules without
change on follow-up US
7 Nodules with decreased
size on follow-up US
63 Nodules with operation
297 Nodules were included
477 Nodules with repeat nondiagnostic results
Excluded 180 nodules without
at least 12 months follow-up US
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were excluded due to the absence of at least 12 months of follow-
up with US or repeat FNAB. A total of 297 nodules with repeat 
nondiagnostic results were included in this study; 153 were found 
to be benign after repeat biopsies, 74 showed no changes during at 
least 12 months of follow-up US, and seven decreased in size (mean 
follow-up, 23 months; range, 12 to 70 months), and 63 underwent 
operation (Fig. 1). Of the total of 297 nodules, 68 were in men 
and 229 were in women. The mean patient age was 52 years±11 
months (range, 23 to 77 years). The mean nodule size was 9.8 mm 
(range, 3 to 81 mm). Clinical information (patient sex and age at the 
time of FNAB, and the dates of US), US findings, and cytopathologic 
records were reviewed for all nodules. 
Imaging Methods and US-Guided FNAB 
US and FNA were performed using 7-15 MHz (HDI 5000; 
Philips Medical Systems, Bothell, WA, USA) and 5-12 MHz linear 
array transducers (iU22; Philips Medical Systems). Real-time US 
examinations were performed by one of six radiologists with one to 
16 years of thyroid imaging experience. Nodule size was defined as 
the maximum diameter on US. The US findings of thyroid nodules 
that underwent FNAB were prospectively analyzed according to 
internal composition, echogenicity, margin, calcifications, shape, and 
vascularity at the time of US. The nodules were classified according 
to internal composition as divided into solid, having a cystic portion 
of 50% or less, and having a cystic portion of over 50%. The nodules 
were classified as hyperechoic, isoechoic, or hypoechoic compared 
to normal thyroid parenchyma; marked hypoechogenicity was 
defined as hypoechoic findings in comparison to the strap muscles. 
The margins were categorized as circumscribed, microlobulated, or 
irregular. Calcifications were classified as microcalcifications (tiny or 
punctuate foci measuring less than 1 mm), macrocalcifications, or no 
calcifications. Shape was designated as parallel or nonparallel (taller 
than wide or greater anteroposterior than transverse direction). 
Vascularity was divided into peripheral (flow during Doppler US only 
at the periphery of the nodule), central (flow during Doppler US 
only in the central portion), both (flow in both sides of the central 
and peripheral portions), or no vascularity. Suspicious malignant US 
findings were solidity, marked hypoechogenicity, microcalcifications, 
microlobulated or irregular margins, and a taller-than-wide shape, in 
accordance with previous reports (Fig. 2A, B) [18]. 
The same radiologist who performed the thyroid US performed 
all US-guided FNABs. FNABs were performed using a free-hand 
technique and a 23-gauge needle attached to a 2-mL disposable 
syringe without an aspirator. Each sample was smeared onto several 
glass slides and immediately alcohol-fixed for Papanicolaou staining. 
The sample remaining in the syringe was rinsed in saline for cell 
blocking. Cytologists did not routinely perform on-site evaluations. 
Pathologists evaluated all nodules according to the Bethesda 
system.  
Fig. 2. Representive sonograms of thyroid nodules with repeat nondiagnostic results.
A. Transverse sonogram in a 67-year-old man with an 11-mm solid nodule (arrowheads) in the right thyroid gland shows marked 
hypoechogenicity, microcalcifications, a microlobulated margin, and a taller-than-wide shape. The nodule was repeatedly nondiagnostic, but 
malignancy was diagnosed upon histopathologic examination after surgery. B. Transverse sonogram in a 57-year-old woman with a 13-mm 
solid nodule (arrowheads) in the left thyroid gland shows isoechogenicity and a well-defined margin. Biopsy was performed due to 18F-2-
fluoro-2-deoxy-D-glucose uptake in positron emission tomography-computed tomography imaging performed as part of follow-up for 
endometrial cancer. The nodule was repeatedly nondiagnostic but was cytologically diagnosed as benign on the third fine-needle aspiration 
biopsy.
A B
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Data and Statistical Analysis
Thyroid nodules were classified as benign or malignant based on 
pathological confirmation during surgery or repeat FNABs. Nodules 
that showed no significant changes or decreased in size over the 
course of at least 12 months of follow-up US were considered 
clinically benign.
Categorical data were classified according to percentages and 
frequencies. We compared malignancy rates, patient characteristics 
(sex and age), and US characteristics (nodule size, composition, 
echogenicity, margin, calcification, shape, vascularity, and number 
of suspicious findings) between benign and malignant nodules in 
repeatedly nondiagnostic nodules. Continuous variables, including 
patient age and nodule size, were analyzed using the Student’s t 
test, while categorical variables, including sex, malignancy rates, and 
US features, were compared using the chi-square test and Fisher 
exact test. In order to assess independent variables of malignancy 
in repeatedly nondiagnostic nodules, multivariate logistic regression 
analysis with a forward stepwise selection method and odds ratios 
(ORs) was performed. These methods were also used to assess 
nodules of all sizes, 10 mm or less, and larger than 10 mm [15,19]. 
In addition, receiver operating characteristic (ROC) curves were 
used to assess the diagnostic value of the number of suspicious 
findings. The cutoff point was analyzed by a ROC curve, such that 
the sum of sensitivity and specificity was maximized. The diagnostic 
sensitivity, specificity, positive predictive value (PPV), negative 
predictive value (NPV), and accuracy were then determined using 
the ROC curves. These methods were also used to assess nodules of 
all sizes, 10 mm or less, and larger than 10 mm. 
Statistical analysis was performed using SAS ver. 9.2 (SAS Institute 
Inc., Cary, NC, USA). P-values <0.05 were considered to indicate 
statistical significance. 
Results
Among 297 nondiagnostic nodules that underwent repeat FNAB, 44 
(14.8%) were surgically diagnosed as malignant (34 conventional, 
eight follicular variant, one cystic variant, and one Hürthle cell 
variant papillary carcinoma), while 253 (85.2%) were diagnosed as 
benign. Of 253 benign nodules, 153 were pathologically confirmed 
as benign on the third through sixth repeat FNABs. Eighty-one 
nodules showed no change or decreased in size over the course of 
follow-up US; the other 19 were surgically confirmed as benign (14 
cases of adenomatous hyperplasia and five fibrotic nodules). 
Marked hypoechogenicity, microlobulated or irregular margins, 
microcalcifications, and taller-than-wide shape occurred significantly 
more often in malignant nodules than in benign nodules (P=0.008, 
P<0.001, P<0.001, and P=0.022, respectively) (Table 1). 
Composition and vascularity did not differ significantly between 
benign and malignant nodules. However, the number of suspicious 
findings did differ significantly between benign and malignant 
nodules (1.95±1.12 vs. 2.82±1.32, respectively; P<0.001) (Table 
1). The results of multivariate logistic regression analysis of clinical 
and US findings in malignant nondiagnostic nodules with repeat 
nondiagnostic results are shown in Table 2. Microcalcifications (OR, 
3.241; 95% confidence interval [CI], 1.504 to 6.985; P=0.003) 
and irregular or microlobulated margins (OR, 2.35; 95% CI, 1.003 
to 5.539; P=0.049) were independent factors associated with 
malignant nodules with nondiagnostic results. Of 216 nodules 
measuring 10 mm or less, 187 (88.6%) and 24 (11.4%) were 
benign and malignant, respectively. Marked hypoechogenicity, 
margin, calcifications, and shape differed significantly between 
benign and malignant nodules (P=0.004, P=0.005, P=0.001, 
and P=0.005, respectively). The number of suspicious findings 
also differed significantly between benign and malignant nodules 
(2.14±1.12 vs. 3.24±1.02, respectively; P<0.001) (Table 3). The 
results of the multivariate logistic regression analysis of clinical and 
US findings in malignant nondiagnostic nodules measuring 10 mm 
or less are shown in Table 4. Only microcalcifications (OR, 4.715; 
95% CI, 1.841 to 12.079; P=0.001) were an independent factor 
associated with malignant nodules measuring 10 mm or less with 
repeated nondiagnostic results. 
Of 81 thyroid nodules larger than 10 mm, 66 (81.5%) were 
benign and 24 (18.5%) were malignant. Only irregular or 
microlobulated margins were significant US findings (P=0.017). 
Other findings, such as composition, echogenicity, calcifications, 
shape, and vascularity did not differ significantly between benign 
and malignant nodules larger than 10 mm. The number of suspicious 
findings was not significantly different between benign and 
malignant nodules (1.38±1.12, vs. 2±1.46, respectively; P=0.071) 
(Table 5). However, considering the small size of our sample, we 
were willing to accept that a P-value of 0.071 for the number of 
suspicious findings can be regarded as a tendency for differentiating 
between benign and malignant nodules, because P-values less than 
0.1 indicate a probable statistical tendency [20,21].
Using the ROC analysis, the best cutoff value for the “number of 
suspicious findings” between benign and malignant nodules was 
three in nodules of all sizes (Table 6) and the area under the curve 
(AUC) was 0.66 (Fig. 3A). Using the best cutoff point, the sensitivity, 
specificity, PPV, NPV, and accuracy were 65.9%, 66.0%, 25.21%, 
91.76%, and 65.99%, respectively. The best cutoff values were three 
in nodules ≤10 mm and two in nodules >10 mm (Table 6). The AUC 
values were 0.70 and 0.61, respectively (Fig. 3B, C). The sensitivity, 
specificity, PPV, NPV, and accuracy were 79.31%, 60.43%, 23.71%, 
94.96%, and 62.96% in nodules 10 mm or less in size and 60%, 
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Table 1. Comparison of malignancy rates with the clinical and ultrasonographic features of repeatedly nondiagnostic thyroid nodules 
according to malignancy and benignity
Characteristic
Malignant nodule
(n=44)
Benign nodule
(n=253)
P-value
Age (yr) 49±10 53±11 0.032
Sex 0.676
Male 35/44 (79.55)a) 194/253 (76.68)
Female 9/44 (20.45) 59/253 (23.32)
Nodule size (mm) 9.89±8.55 10±8.46 0.935
Composition 0.380
Solid 39/44 (88.64)b) 202/253 (79.84)
Cystic portion ≤50% 5/44 (11.36) 41/253 (16.21)
Cystic portion >50% 0/44 (0) 110/253 (3.95)
Echogenicity 0.008
Hyperechogenicity 0/44 (0) 0/253 (0)
Isoechogenicity 3/44 (6.82) 51/253 (20.16)
Hypoechogenicity 30/44 (68.18) 175/253 (69.17)
Marked hypoechogenicity 11/44 (25) 27/253 (10.67)
Margin <0.001
Well-defined 9/44 (20.45) 118/253 (46.64)
Microlobulated 6/44 (13.64) 43/253 (17)
Irregular 29/44 (65.91) 92/253 (36.36)
Calcification
No calcifications 14/44 (31.82) 31/253 (12.25) <0.001
Microcalcifications 5/44 (11.36) 85/253 (33.6)
Macrocalcifications 25/44 (56.82) 137/253 (54.15)
Shape 0.022
Wider than tall 19/44 (43.18) 156/253 (61.66)
Taller than wide 25/44 (56.82) 97/253 (38.34)
Vascularity 0.799
Peripheral 13/44 (29.55) 85/253 (33.6)
Central 1/44 (2.27) 6/253 (2.37)
Both 8/44 (18.18) 33/253 (13.04)
None 22/44 (50) 129/253 (50.99)
No. of suspicious findings 2.82±1.32 1.95±1.12 <0.001
 Values are presented as mean±SD or number (%).
a)Number of patients divided bytotal patients. b)Number of nodules with the feature divided by total nodules.
Table 2. Multivariate analysis of clinical and ultrasound characteristics for predicting the malignancy of repeatedly nondiagnostic 
nodules
Variable OR (95% CI) P-value
Echogenicity (marked hypoechogenicity) 2.034 (0.862-4.800) 0.105
Microcalcifications 3.241 (1.504-6.985) 0.003
Margin (irregular/microlobulated) 2.35 (1.003-5.539) 0.049
Shape (nonparallel) 1.412 (0.003-5.539) 0.348
 OR, odds ratio; CI, confidence interval.
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Discussion
High nondiagnostic and malignancy rates in repeatedly nondiagnostic 
nodules present a diagnostic dilemma for clinicians and radiologists, 
62.12%, 26.47%, 87.23%, and 61.73% in nodules larger than 10 
mm, respectively (Table 6). 
Table 4. Multivariate analysis of clinical and ultrasound characteristics for predicting malignancy in repeatedly nondiagnostic nodules 
measuring 10 mm or less
Variable OR (95% CI) P-value
Echogenicity (marked hypoechogenicity) 2.509 (0.919-6.846) 0.073
Microcalcifications 4.715 (1.841-12.079) 0.001
Margin (irregular/microlobulated) 3.414 (0.907-12.851) 0.069
Shape (nonparallel) 2.140 (0.826-5.545) 0.117
 OR, odds ratio; CI, confidence interval.
Table 3. Comparison of malignancy rates with the clinical and ultrasonographic features of repeatedly nondiagnostic nodules 
measuring 10 mm or less according to malignancy and benignity
Characteristic
Malignant nodule
(n=29)
Benign nodule
(n=187)
P-value
Composition 0.399
Solid 27/29 (93.1)a) 158/187 (84.5)
Cystic portion ≤50% 2/29 (6.9) 22/187 (11.8)
Cystic portion >50% 0/29 (0) 7/187 (3.7)
Echogenicity 0.004
Hyperechogenicity 0/29 (0) 0/187 (0)
Isoechogenicity 0/29 (0) 28/187 (15.0)
Hypoechogenicity 20/29 (69.0) 137/187 (73.3)
Marked hypoechogenicity 9/29 (31.0) 22/187 (11.8)
Margin 0.005
Well-defined 3/29 (10.3) 73/187 (39.0)
Microlobulated 5/29 (17.2) 34/187 (18.2)
Irregular 21/29 (72.4) 80/187 (42.8)
Calcification 0.001
No calcifications 11/29 (37.9) 24/187 (12.8)
Microcalcifications 5/29 (17.2) 66/187 (35.3)
Macrocalcifications 21/29 (72.4) 97/187 (51.9)
Shape 0.005
Wider than tall 8/29 (27.6) 104/187 (55.6)
Taller than wide 21/29 (72.4) 83/187 (44.4)
Vascularity 0.854
Peripheral 9/29 (31.0) 47/187 (25.1)
Central 1/29 (3.4) 5/187 (2.7)
Both 2/29 (6.9) 20/187 (10.7)
None 17/29 (58.6) 115/187 (61.5)
No. of suspicious findings 3.24±1.02 2.14±1.12 <0.001
 Values are presented as number (%).
a)Number of nodules with the feature divided by total nodules.
Na Lae Eun, et al.
240  Ultrasonography 35(3), July 2016 e-ultrasonography.org
who must decide whether to continue repeat FNABs (or surgical 
intervention) or to perform follow-up US. According to the ATA 
and AACE guidelines, surgery is recommended for solid nodules 
and surgery or observation for cystic nodules [14,15]. However, 
surgery for all solid nodules is not cost-effective and can lead to 
postoperative morbidity in patients. Several studies and guidelines 
have suggested that nondiagnostic nodules with certain US features 
be followed up with US rather than repeat biopsies. Yoon et al. 
Table 6. Optimal cutoff values, sensitivity, specificity, predictive values, and accuracy using the number of suspicious findingsa) for 
differentiating between malignancy and benignity in repeatedly nondiagnostic thyroid nodules
Size Cutoff Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
All >2 65.90 66.00 25.22 91.76 65.99
≤10 mm >2 79.31 60.43 23.71 94.96 62.96
>10 mm >1 60 62.12 26.47 87.23 61.73
 PPV, positive predictive value; NPV, negative predictive value.
a)Suspicious malignant ultrasonographic findings were solidity, marked hypoechogenicity, microcalcifications, microlobulated or irregular margins, and taller-than-wide shape.
Table 5. Comparison of malignancy rates with the clinical and ultrasonographic features of repeatedly nondiagnostic thyroid nodules 
measuring larger than 10 mm according to malignancy and benignity
Characteristic
Malignant nodule
(n=15)
Benign nodule
(n=66)
P-value
Composition 0.511
Solid 12/15 (80.0)a) 44/66 (66.7)
Cystic portion ≤50% 3/15 (20.0) 19/66 (28.8)
Cystic portion >50% 0/15 (0) 3/66 (4.5)
Echogenicity 0.477
Hyperechogenicity 0/15 (0) 0/66 (0)
Isoechogenicity 3/15 (20.0) 23/66 (34.8)
Hypoechogenicity 10/15 (66.7) 38/66 (57.6)
Marked hypoechogenicity 2/15 (13.3) 5/66 (7.6)
Margin 0.017
Well-defined 6/15 (40.0) 45/66 (68.2)
Microlobulated 1/15 (6.7) 9/66 (13.6)
Irregular 8/15 (53.3) 12/66 (18.2)
Calcification 0.355
No calcifications 3/15 (20.0) 7/66 (10.6)
Microcalcifications 2/15 (13.3) 19/66 (28.8)
Macrocalcifications 10/15 (66.7) 40/66 (60.6)
Shape 0.646
Wider than tall 11/15 (73.6) 52/66 (78.8)
Taller than wide 4/15 (26.7) 14/66 (21.2)
Vascularity 0.145
Peripheral 4/15 (26.7) 38/66 (57.6)
Central 0/15 (0) 1/66 (1.5)
Both 6/15 (40.0) 13/66 (19.7)
None 6/15 (33.3) 14/66 (21.1)
No. of suspicious findings 2±1.46 1.38±1.12 0.071
 Values are presented as number (%) or mean±SD.
a)Number of nodules with the feature divided by total nodules.
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[22] proposed that nodules with no suspicious features, especially 
mainly cystic nodules, should be followed up with US. In our study, 
none of the nodules with greater than 50% cystic portions were 
malignant, consistent with previous findings. Woo et al. [20] recently 
suggested that hypoechogenicity was an independently significant 
factor in nodules with repeated nondiagnostic cytology; however, no 
significant correlation was found in our multivariate analysis.   
The results of our study showed that the US features of 
marked hypoechogenicity, microlobulated or irregular margins, 
microcalcifications, and nonparallel shape, which have been reported 
to be significant in a previous study [18], differed significantly 
between benign and malignant nodules in repeatedly nondiagnostic 
nodules. Microcalcifications (OR, 3.241; 95% CI, 1.504 to 6.985; 
P=0.003) and microlobulated or irregular margins (OR, 2.35; 95% 
CI, 1.003 to 5.539; P=0.049) were independent factors predicting 
malignancy in multivariate regression analysis. Among them, only 
microcalcifications were found to be significant in a multivariate 
analysis between benign and malignant nodules measuring 10 mm 
or less (OR, 4.715; 95% CI, 1.841 to 12.079; P=0.001). In nodules 
larger than 10 mm, however, only microlobulated or irregular 
Fig. 3. Receiver operating characteristic curves for the number 
of suspicious findings in the differentiation of malignancy and 
benignity in repeatedly nondiagnostic thyroid nodules. 
A. Area under the curve (AUC) value in nodules with all sizes was 
0.66. B. AUC value in nodules measuring 10 mm or less was 0.70. C. 
AUC value in nodules larger than 10 mm was 0.61.
A B
C
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margins differed significantly between benign and malignant groups 
(P=0.014). These discrepancies may be due to the associations 
between many significant factors in small nodules, in contrast 
to larger nodules, which showed only one significant finding 
(microlobulated or irregular margins).
Some authors have proposed that follow-up US is preferable 
to repeat FNAB and surgery for nondiagnostic nodules [7,16]; 
several reports have suggested that diagnostic options should be 
evaluated according to US findings [10,12,17,20]. Moon et al. 
[17] recommended surgery for repeatedly nondiagnostic nodules 
showing one or more suspicious features. Recently, Moon et al. 
[10] proposed that the Thyroid Imaging Reporting and Data System, 
developed by Kwak et al. [12], can be used to stratify the risk of 
malignancy associated with initially nondiagnostic nodules. They 
concluded that nondiagnostic thyroid nodules without suspicious 
US features or one suspicious feature can be followed up using US, 
but those with two or more suspicious features should undergo 
repeat US-guided FNAB. Our study also showed that the number 
of suspicious features (including solidity, marked hypoechogenicity, 
microcalcifications, microlobulated or irregular margins, and taller-
than-wide shape [18]) differed significantly between benign and 
malignant nodules with repeat nondiagnostic findings (2.82±1.32 
vs. 1.95±1.12, respectively; P<0.001), which supports the proposal 
that the number of suspicious US findings is an important factor 
in deciding whether to perform follow-up examinations on thyroid 
nodules with repeatedly nondiagnostic results. In nodules measuring 
larger than 10 mm, however, the number of suspicious findings was 
not significantly different between benign and malignant nodules 
(1.38±1.12 vs. 2±1.46, respectively; P=0.071). However, in light of 
our small sample size, we considered that a tendency existed for the 
number of suspicious findings to differentiate benign and malignant 
nodules [20,21]. 
In our study, the cutoff value for the number of suspicious 
findings was three in nodules of all sizes and in those measuring 10 
mm or less, and two in nodules larger than 10 mm. The sensitivity, 
specificity, PPV, NPV, and accuracy were 65.9%, 66.0%, 25.21%, 
91.76%, and 65.99% in nodules of all sizes, and 79.31%, 60.43%, 
23.71%, 94.96%, and 62.96% in nodules 10 mm in size or 
smaller and 60%, 62.12%, 26.47%, 87.23%, and 61.73% in 
nodules larger than 10 mm, respectively. Although the diagnostic 
performance was not optimal, we can recommend repeat biopsy or 
surgery in nodules with two or more suspicious findings to detect 
malignancy in repeatedly nondiagnostic nodules.
In thyroid nodules with repeatedly nondiagnostic results, the 
third FNAB is less likely to be diagnostic; however, it can be useful 
in some patients. Our study showed that 153 out of 477 nodules 
(32.1%) were diagnostic. Core-needle biopsy (CNB) can be an 
alternative to repeat biopsy or surgery in thyroid nodules with prior 
nondiagnostic results [23-26]. Adjunctive CNB performed along 
with FNAB showed higher accuracy than FNAB alone (94% vs. 
82%) [25]. The nondiagnostic results ranged from 1.2% to 26% of 
CNBs, which was superior to the results of repeat FNAB [23-26]. 
To our knowledge, the current study is one of the largest 
population-based studies of nodules with repeated nondiagnostic 
cytology. However, our study has several limitations. First, selection 
bias may have been present, since 795 initially nondiagnostic 
nodules were excluded due to the lack of a second FNAB and 180 
nodules were excluded due to the absence of at least 12 months 
of follow-up US data. The small proportion of cystic nodules in our 
study may also have resulted in selection bias. Second, nodules 
showing no changes in size or decreased size over at least 12 
months of follow-up US were considered benign in this study, and 
some errors may have been present in the malignancy rate because 
decisions were made regarding surgery or repeat biopsies according 
to the preferences of the clinicians and/or patients. Third, the 
AUC values for the “number of suspicious findings” as a criterion 
for differentiating between benign and malignant nodules were 
suboptimal (0.61-0.70), making the clinical applicability of these 
data limited. Fourth, in nodules measuring >10 mm, the P-value 
of 0.071 was regarded as indicating a tendency for the number of 
suspicious findings to differentiate between benign and malignant 
nodules, considering the small sample size. Further studies with 
larger population groups should be performed.
In conclusion, irregular or microlobulated margins were the US 
finding with the greatest ability to predict malignancy in repeatedly 
nondiagnostic nodules larger than 10 mm. The best cutoff value 
for distinguishing between benign and malignant nodules was the 
presence of two or more suspicious findings. 
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